Election Boost For Taiwan Biopharma Industry?
This article was originally published in PharmAsia News
Last week’s presidential election in Taiwan saw biotech stocks surge on the back of expectations the island’s newly elected president - a biotech company founder - will rapidly discuss and implement policies positive for the sector as she seeks to position it as a strategic economic growth engine.
You may also be interested in...
WuXi Biologics is aiming high to become the world’s biggest biologics manufacturer within five years after seeing strong confidence from capital markets in its growth potential and a boost from its new biologics manufacturing facility. The Chinese company plans on more investment in early 2018 to prepare for an expected biologics surge in China, its chief executive tells Scrip.
Continuing with a double-digit growth rate, China remained a leading driver for Sanofi’s global business in the fourth quarter. Going digital and building local partnerships emerged as key themes for Sanofi China to explore more opportunities, although it may face testing problems for its vaccine business in the country.